| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |